InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Cash & Current Investments (2016 - 2026)

InflaRx (IFRX) posted Cash & Current Investments of $46.6 million for Q1 2026, down 13.84% sequentially from $54.1 million in Q4 2025, and down 6.79% YoY from $50.0 million in Q1 2025.

InflaRx (IFRX) Cash & Current Investments (2016 - 2026) Analysis & Trends

InflaRx has reported Cash & Current Investments for 11 years, with the latest figure at $46.6 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 6.79% year-over-year to $46.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.6 million (down 6.79% YoY) and the FY2025 annual result came in at $52.5 million, down 8.26% from the prior year.
  • Cash & Current Investments retreated to $46.6 million in Q1 2026 per IFRX's latest filing, from $54.1 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $101.0 million in Q1 2022 and troughed at $10.8 million in Q1 2023.
  • A 5-year average of $40.2 million and a median of $41.9 million in 2023 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2023 and 2024: Cash & Current Investments tumbled 89.31% in 2023, then soared 177.44% in 2024.
  • Over 5 years, Cash & Current Investments stood at $19.6 million in 2022, then gained by 20.06% to $23.5 million in 2023, then surged by 140.6% to $56.5 million in 2024, then dropped by 4.27% to $54.1 million in 2025, then fell by 13.84% to $46.6 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $46.6 million, $54.1 million, and $52.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn 184.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 46.60 Mn
Dec 31, 2025 54.08 Mn
Sep 30, 2025 52.19 Mn
Jun 30, 2025 54.33 Mn
Mar 31, 2025 49.99 Mn
Dec 31, 2024 56.49 Mn
Sep 30, 2024 63.58 Mn
Jun 30, 2024 20.88 Mn
Mar 31, 2024 29.98 Mn
Dec 31, 2023 23.48 Mn
Sep 30, 2023 23.88 Mn
Jun 30, 2023 41.89 Mn
Mar 31, 2023 10.80 Mn
Dec 31, 2022 19.55 Mn
Sep 30, 2022 18.37 Mn
Jun 30, 2022 16.70 Mn
Mar 31, 2022 101.03 Mn
Dec 31, 2021 61.15 Mn
Sep 30, 2021 34.74 Mn
Jun 30, 2021 153.18 Mn